Typeless

Typeless

Optimizes medical documentation with AI.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round

N/A

Acquisition
Total Funding000k
Notes (0)
More about Typeless
Made with AI
Edit

Typeless, founded in Lausanne, Switzerland, in 2022, is a technology firm that has developed an advanced AI-powered platform for the healthcare sector. The company was established by a team that includes CEO Matthieu Le Cauchois, CTO Aurélien Morel, COO Dana Ghosn, and CSO Maxime Vidal. Typeless originated as a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL) and received early backing from accelerator programs, including Berkeley SkyDeck and the EPFL.

The core of Typeless's offering is a sophisticated application designed for medical speech and text comprehension. The platform utilizes Large Language Models (LLM) to convert spoken conversations between doctors and patients into structured, usable text. This technology aims to alleviate the significant administrative burden on healthcare professionals by automating the process of creating medical notes and reports from unstructured sources like conversations and handwritten notes. Its features include state-of-the-art medical speech transcription that accurately captures specialized vocabulary, automatic formatting to ensure regulatory compliance, and the ability to extract key medical information such as symptoms, diagnoses, and treatments. The system is designed to integrate with existing Electronic Health Record (EHR) systems via an API or be used as a standalone web application. The service is GDPR and FADP compliant, ensuring patient data is handled securely.

The company's business model is centered on providing its software-as-a-service (SaaS) platform to healthcare professionals and institutions. By transforming unstructured data into computable, organized information, the platform helps improve daily workflows, clinical operations, and ultimately, the patient journey. In a significant milestone, Typeless was acquired by the European healthtech company Doctolib in June 2024. This acquisition is part of Doctolib's strategy to enhance its AI capabilities and accelerate the development of a digital medical assistant. The Typeless team, with its expertise in data science and AI, was integrated into Doctolib to support these development efforts.

Keywords: medical speech recognition, healthcare AI, clinical documentation, medical transcription, large language models, healthtech, SaaS, EPFL spin-off, patient journey, clinical data management, electronic health records, Doctolib, Matthieu Le Cauchois, Aurélien Morel, Dana Ghosn, Maxime Vidal, medical data extraction, unstructured data analysis, healthcare administration, medical reporting automation, digital health

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads